Introducing the MultiPro® Human Discovery Panel
Proteintech Genomics, recognized as a leader in the arena of antibody-based multiplexed solutions for single-cell multiomics, has unveiled their latest offering: the MultiPro® Human Discovery Panel. This exceptional tool is poised to significantly enhance single-cell multiomics research, enabling scientists to examine 325 proteins along with a comprehensive transcriptome analysis from individual cells. The innovative multiomic approach positions researchers to gain profound insights into the intricate functionalities of cellular behaviors.
Advanced Technology Behind the MultiPro® Panel
The MultiPro® Human Discovery Panel utilizes the cutting-edge 10x Genomics’ Chromium Single Cell Gene Expression Flex chemistry combined with Feature Barcode technology. This unique capability allows scientists to investigate both intracellular proteins and those present on the surface of cells, fostering a richer understanding of cellular interactions through more in-depth multiomic analyses. With an impressive arsenal of 346 antibodies targeting 325 distinct proteins, this panel greatly enhances the coverage of crucial cellular elements. Notably, two-thirds of these protein targets are located within cells, while the remaining third resides on the cell surfaces, providing extensive data for researchers.
Cost Efficiency and Accessibility for Researchers
The MultiPro® Human Discovery Panel distinguishes itself through outstanding cost-effectiveness. It achieves comprehensive protein profiling at less than half the price of similar products available in the market. This pricing strategy positions advanced, high-resolution multiomic analysis within reach for many researchers, facilitating broader access to powerful scientific tools that can catalyze discovery.
Expert Insights on the Launch
Dr. Kit Nazor, CEO of Proteintech Genomics, expressed his enthusiasm, stating, "As we continue to push the boundaries of cellular analysis, the MultiPro® Human Discovery Panel provides an unprecedented opportunity for researchers to explore cellular functions in greater depth and clarity than ever, while offering cost-efficiency that is unparalleled in the market." Additionally, Dr. Peter Smibert, VP of Biology at 10x Genomics, highlighted the significance of this panel for comprehensive analysis: “The simultaneous profiling of the whole transcriptome along with the vast array of proteins through the MultiPro® panel marks a pivotal advancement for multiomic characterization of single cells.”
Impact on Research Fields
This launch signifies a substantial leap forward for multiomic analysis, enabling researchers to delve deeper into fields such as immunology, oncology, and cell biology. With the MultiPro® Human Discovery Panel, Proteintech Genomics aims to empower scientists to enhance their investigations, driving breakthroughs that can reshape our understanding of complex biological systems.
About Proteintech Genomics
Proteintech Genomics, a key subsidiary of Proteintech Group, is devoted to delivering pioneering tools for cellular multiomics. Leveraging an extensive antibody catalog, the company develops innovative solutions tailored for proteomics and genomics, focusing on single-cell and spatial technologies. With its headquarters in San Diego, Proteintech Genomics is positioned at the forefront of multiomic innovation, enabling researchers globally to achieve groundbreaking advancements in their studies.
Frequently Asked Questions
What is the MultiPro® Human Discovery Panel?
The MultiPro® Human Discovery Panel is an advanced antibody panel designed for single-cell multiomics, enabling the profiling of proteins and transcriptomes simultaneously.
How does the MultiPro® panel enhance cellular analysis?
It allows researchers to analyze both intracellular and cell-surface proteins, providing a comprehensive understanding of cellular functions.
What makes this panel cost-effective?
The MultiPro® panel offers extensive profiling capabilities at less than half the cost of similar products on the market.
Which proteins can researchers target with this panel?
The panel targets 325 distinct proteins, including transcription factors, cytokines, and signaling proteins, among others.
Who are the key individuals leading Proteintech Genomics?
Dr. Kit Nazor serves as the CEO, with Dr. Peter Smibert acting as the VP of Biology at 10x Genomics, which partnered in the development of this panel.
